BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38317077)

  • 1. Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial.
    Murphy RJ; Godfrey K; Shaw AD; Muthukumaraswamy S; Sumner RL
    BMC Neurosci; 2024 Feb; 25(1):7. PubMed ID: 38317077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.
    Murphy RJ; Sumner RL; Evans W; Menkes D; Lambrecht I; Ponton R; Sundram F; Hoeh N; Ram S; Reynolds L; Muthukumaraswamy S
    Trials; 2021 Apr; 22(1):302. PubMed ID: 33892777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD increases sleep duration the night after microdosing.
    Allen N; Jeremiah A; Murphy R; Sumner R; Forsyth A; Hoeh N; Menkes DB; Evans W; Muthukumaraswamy S; Sundram F; Roop P
    Transl Psychiatry; 2024 Apr; 14(1):191. PubMed ID: 38622150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.
    Murray CH; Tare I; Perry CM; Malina M; Lee R; de Wit H
    Psychopharmacology (Berl); 2022 Jun; 239(6):1735-1747. PubMed ID: 34613430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling thalamocortical circuitry shows that visually induced LTP changes laminar connectivity in human visual cortex.
    Sumner RL; Spriggs MJ; Shaw AD
    PLoS Comput Biol; 2021 Jan; 17(1):e1008414. PubMed ID: 33476341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.
    Murphy RJ; Sumner R; Evans W; Ponton R; Ram S; Godfrey K; Forsyth A; Cavadino A; Krishnamurthy Naga V; Smith T; Hoeh NR; Menkes DB; Muthukumaraswamy S
    Biol Psychiatry; 2023 Sep; 94(6):511-521. PubMed ID: 36997080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosing Psychedelics: Current Evidence From Controlled Studies.
    Murphy RJ; Muthukumaraswamy S; de Wit H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):500-511. PubMed ID: 38280630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Visual Long-Term Potentiation Show Preserved Cyclicity in Human Females Taking Combined Oral Contraceptives.
    Stone E; Alshakhouri M; Shaw A; Muthukumaraswamy S; Sumner RL
    Neuroendocrinology; 2023; 113(8):859-874. PubMed ID: 37094560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity.
    Glazer J; Murray CH; Nusslock R; Lee R; de Wit H
    Neuropsychopharmacology; 2023 Jan; 48(2):418-426. PubMed ID: 36284231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility.
    Wießner I; Olivieri R; Falchi M; Palhano-Fontes F; Oliveira Maia L; Feilding A; B Araujo D; Ribeiro S; Tófoli LF
    Eur Neuropsychopharmacol; 2022 May; 58():7-19. PubMed ID: 35158230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
    Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
    Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
    Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder.
    Sumner RL; McMillan R; Spriggs MJ; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Kirk IJ; Sundram F; Muthukumaraswamy SD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Jan; 5(1):45-55. PubMed ID: 31495712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
    Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
    J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Hebbian learning in human perception: a methodological and theoretical review of the human Visual Long-Term Potentiation paradigm.
    Sumner RL; Spriggs MJ; Muthukumaraswamy SD; Kirk IJ
    Neurosci Biobehav Rev; 2020 Aug; 115():220-237. PubMed ID: 32562886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.
    Timmermann C; Spriggs MJ; Kaelen M; Leech R; Nutt DJ; Moran RJ; Carhart-Harris RL; Muthukumaraswamy SD
    Neuropharmacology; 2018 Nov; 142():251-262. PubMed ID: 29101022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
    Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
    Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.
    Bedford P; Hauke DJ; Wang Z; Roth V; Nagy-Huber M; Holze F; Ley L; Vizeli P; Liechti ME; Borgwardt S; Müller F; Diaconescu AO
    Neuropsychopharmacology; 2023 Jul; 48(8):1175-1183. PubMed ID: 37185950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing Psychedelics and MDMA.
    Liechti ME; Holze F
    Curr Top Behav Neurosci; 2022; 56():3-21. PubMed ID: 34734392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.